公开(公告)号：US07608709B2

公开(公告)日：2009-10-27

申请号：US11359369

申请日：2006-02-23

申请人： Tsuneo Imamoto ,  Kazuhiro Yoshida ,  Keitaro Sugita

发明人： Tsuneo Imamoto ,  Kazuhiro Yoshida ,  Keitaro Sugita

IPC分类号： C07F9/535

CPC分类号： C07F15/008 ,  C07F9/650952

摘要： An optically active 2,3-bis(dialkylphosphino)pyrazine derivative represented by formula (1) is disclosed. The pyrazine derivative is preferably a quinoxaline derivative represented by formula (2). In formula (1) and (2), R1 is preferably a t-butyl or adamantyl group, and R2 is preferably a methyl group. wherein R1 is a substitutable straight chain or branched alkyl group having 2 to 10 carbon atoms; R2 is a substitutable straight chain or branched alkyl group having fewer carbon atoms than R1; and R3 and R4, which may be the same or different, are each a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, or R3 and R4 are taken together to form a saturated or unsaturated ring. wherein R1 and R2 are as defined above; and R5 is a monovalent substituent.

摘要翻译： 公开了由式（1）表示的光学活性2,3-双（二烷基膦基）吡嗪衍生物。 吡嗪衍生物优选为式（2）表示的喹喔啉衍生物。 在式（1）和（2）中，R1优选为叔丁基或金刚烷基，R2优选为甲基。 其中R1是具有2-10个碳原子的可取代的直链或支链烷基; R2是具有比R1少的碳原子的可取代的直链或支链烷基; 和可以相同或不同的R 3和R 4各自为氢原子或具有1至6个碳原子的烷基，或者R 3和R 4一起形成饱和或不饱和的环。 其中R1和R2如上所定义; R5是一价取代基。

公开(公告)号：US20070021610A1

公开(公告)日：2007-01-25

申请号：US11359369

申请日：2006-02-23

申请人： Tsuneo Imamoto ,  Kazuhiro Yoshida ,  Keitaro Sugita

发明人： Tsuneo Imamoto ,  Kazuhiro Yoshida ,  Keitaro Sugita

IPC分类号： C07F15/00 ,  C07F9/6509

CPC分类号： C07F15/008 ,  C07F9/650952

摘要： An optically active 2,3-bis(dialkylphosphino)pyrazine derivative represented by formula (1) is disclosed. The pyrazine derivative is preferably a quinoxaline derivative represented by formula (2). In formula (1) and (2), R1 is preferably a t-butyl or adamantyl group, and R2 is preferably a methyl group. wherein R1 is a substituted or unsubstituted, straight chain or branched alkyl group having 2 to 10 carbon atoms; R2 is a substituted or unsubstituted, straight chain or branched alkyl group having fewer carbon atoms than R1; and R3 and R4, which may be the same or different, are each a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, or R3 and R4 are taken together to form a saturated or unsaturated ring. wherein R1 and R2 are as defined above; and R5 is a monovalent substituent.

摘要翻译： 公开了由式（1）表示的光学活性2,3-双（二烷基膦基）吡嗪衍生物。 吡嗪衍生物优选为式（2）表示的喹喔啉衍生物。 式（1）和（2）中，R 1优选为叔丁基或金刚烷基，R 2优选为甲基。 其中R 1是具有2至10个碳原子的取代或未取代的直链或支链烷基; R 2是具有比R 1更少的碳原子的取代或未取代的直链或支链烷基; R 3和R 4可以相同或不同，分别为氢原子或具有1-6个碳原子的烷基，或R“ 3和R 4一起形成饱和或不饱和的环。 其中R 1和R 2如上定义; R 5是一价取代基。